Differential selective pressure alters rate of drug resistance acquisition in heterogeneous tumor populations
Recent drug discovery and development efforts have created a large arsenal of targeted and chemotherapeutic drugs for precision medicine. However, drug resistance remains a major challenge as minor pre-existing resistant subpopulations are often found to be enriched at relapse. Current drug design h...
Main Authors: | Sun, Daphne S. (Contributor), Dalin, Simona (Contributor), Hemann, Michael (Contributor), Lauffenburger, Douglas A (Contributor), Zhao, Boyang (Contributor) |
---|---|
Other Authors: | Koch Institute for Integrative Cancer Research at MIT (Contributor), Massachusetts Institute of Technology. Computational and Systems Biology Program (Contributor), Massachusetts Institute of Technology. Department of Biological Engineering (Contributor), Massachusetts Institute of Technology. Department of Biology (Contributor), Massachusetts Institute of Technology. Department of Chemical Engineering (Contributor) |
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group,
2017-06-12T13:57:13Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Intratumor heterogeneity alters most effective drugs in designed combinations
by: Zhao, Boyang, et al.
Published: (2015) -
Modeling Tumor Clonal Evolution for Drug Combinations Design
by: Zhao, Boyang, et al.
Published: (2018) -
Addressing Genetic Tumor Heterogeneity through Computationally Predictive Combination Therapy
by: Zhao, Boyang, et al.
Published: (2014) -
Architectural Heterogeneity in Tumors Caused by Differentiation
Alters Intratumoral Drug Distribution and Affects Therapeutic Synergy of Antiangiogenic Organoselenium Compound
by: Youcef M. Rustum, et al.
Published: (2010-01-01) -
Exploiting Temporal Collateral Sensitivity in Tumor Clonal Evolution
by: Zhao, Boyang, et al.
Published: (2017)